John Kane

Dr. John Kane, a distinguished psychiatrist with decades of experience, dives deep into clozapine, a revolutionary medication for treatment-resistant schizophrenia. He shares its tumultuous history, including safety concerns that challenged its FDA approval. Dr. Kane highlights the drug's underutilization and intricate monitoring requirements that complicate patient access. The discussion extends to new advancements in schizophrenia treatments, underscoring the urgent need for comprehensive education for patients and families in navigating these complex issues.